Autologous dendritic cell vaccine expressing Her-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous dendritic cell vaccine expressing Her-2, covering 2012-11-01 to 2012-11-01. Get the full timeline:
Most recent: Clinical Trial Update: Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2 [Phase 1]